Modalis Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
Modalis Therapeutics has a total shareholder equity of ¥1.4B and total debt of ¥412.0M, which brings its debt-to-equity ratio to 29.9%. Its total assets and total liabilities are ¥2.0B and ¥646.0M respectively.
Key information
29.9%
Debt to equity ratio
JP¥412.00m
Debt
Interest coverage ratio | n/a |
Cash | JP¥1.88b |
Equity | JP¥1.38b |
Total liabilities | JP¥646.00m |
Total assets | JP¥2.03b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4883's short term assets (¥2.0B) exceed its short term liabilities (¥198.0M).
Long Term Liabilities: 4883's short term assets (¥2.0B) exceed its long term liabilities (¥448.0M).
Debt to Equity History and Analysis
Debt Level: 4883 has more cash than its total debt.
Reducing Debt: 4883's debt to equity ratio has increased from 0% to 29.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4883 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 4883 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 42.4% each year